Researchers found that selectively suppressing a PRLR isoform reduced pathogenic immune-cell activity and prevented early kidney abnormalities in lupus-prone mice.
Investigators identified 2 histamine-related genes associated with keratoconjunctivitis sicca and found that suppressing either gene reduced inflammatory injury in corneal epithelial cells.
In 2 phase 3 trials, about half of treated patients achieved at least 80% scalp hair coverage by week 24, with additional improvements in eyebrow and eyelash regrowth.
Investigators found that symptom improvement remained possible years after infection, but patients with multisystem symptoms had lower likelihood of improvement.